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Abstract
Objective—Despite a growing number of women seeking medical care in the VA system, little is
known about the characteristics of their chronic pain or the pain care they receive. This study
sought to determine if sex differences are present in the medical care veterans received for chronic
pain.
Design—Retrospective cohort study using VA administrative data.
Subjects—17,583 veteran patients with moderate to severe chronic non-cancer pain treated in
the Pacific Northwest during 2008.
Methods—Multivariate logistic regression assessed for sex differences in primary care
utilization, prescription of chronic opioid therapy, visits to emergency departments for a painrelated diagnosis, and physical therapy referral.
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Results—Compared to male veterans, female veterans were more often diagnosed with two or
more pain conditions and had more of the following pain-related diagnoses: fibromyalgia, low
back pain, inflammatory bowel disease, migraine headache, neck or joint pain, and arthritis. After
adjustment for demographic characteristics, pain diagnoses, mental health diagnoses, substance
use disorders, and medical comorbidity, women had lower odds of being prescribed chronic opioid
therapy (AOR 0.67, 95% CI 0.58–0.78), greater odds of visiting an emergency department for a
pain-related complaint (AOR 1.40, 95% CI 1.18–1.65), and greater odds of receiving physical
therapy (AOR 1.19, 95% CI 1.05–1.33). Primary care utilization was not significantly different
between sexes.
Conclusions—Sex differences are present in the care female veterans receive for chronic pain.
Further research is necessary to understand the etiology of the observed differences and their
associations with clinical outcomes.
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Introduction
Chronic pain is prevalent in the general population and is a frequent reason for primary care
visits (1, 2), though, women may be more likely than men to seek medical care for pain (3–
7). Sex is also associated with important differences in patients’ report of pain and certain
pain diagnoses are more prevalent in women. For instance, women have a higher prevalence
of severe pain (4, 8–11) and pain syndromes like migraine headache (4, 12, 13),
fibromyalgia (14), oral-facial pain (4, 8), and abdominal pain (4, 8). Accordingly, women
have higher health care utilization and costs associated with their pain care (15, 16).
Epidemiologic data also suggests that women, especially older women, are more likely to
receive chronic opioid therapy (COT) for pain (16, 17).
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Chronic pain impacts up to 50% of veterans who seek care in the VA (2). Similar to
civilians, female veterans are more likely to report moderate to severe pain (18) and appear
to have a higher prevalence of pain (19). Little empirical information is available describing
the medical care veterans receive for chronic pain based on sex. Given that the number of
female veterans is rapidly increasing and that there are unique access issues for women in
the VA system (20), it is important to understand potential sex differences in the medical
care veterans receive for chronic pain, as outlined in the 2012 Women Veterans Task Force
goals and objectives (20). This information will also help the VA improve its chronic pain
care for veterans, in keeping with the 2011 Institute of Medicine report on pain care and
research (21).
The main objective of this study was to determine if sex differences exist in certain types of
medical care in VA patients with chronic pain. We specifically examined primary care
utilization, prescription of COT, emergency department (ED) visits, and participation in
physical therapy. A secondary objective was to examine sex differences in the
characteristics of COT amongst veterans prescribed COT.

Methods
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We extracted data for this retrospective cohort study from the Veterans Integrated Service
Network-20 (VISN-20) Data Warehouse from 2008. The VISN-20 comprises Veterans
Affairs (VA) medical facilities in Washington, Oregon, Idaho, and Alaska. The VISN-20
Data Warehouse contains data from the main clinical software packages of regional VA
healthcare facilities and two national VA databases (22). All VA clinical contacts are
recorded in an electronic medical record (EMR); data used in this study were obtained from
the EMR. This study was approved by the local VA Medical Center Institutional Review
Board.
Inclusion/Exclusion criteria
Veterans who received any medical care in VISN-20 during calendar year 2008 were
eligible. Included subjects were patients reporting moderate to severe non-cancer pain of at
least three months duration. The Numeric Rating Scale (NRS) is a validated and practical
measure of pain intensity and is routinely and frequently administered to veterans presenting
for care in the VA system (23). The NRS is a 0–10 scale with 0 being no pain and 10 being
worst possible pain and is recorded at outpatient visits as part of the VA’s “Pain as a 5th
Vital Sign” initiative (23, 24). Moderate to severe chronic non-cancer pain (CNCP) was
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defined as patient reported pain intensity of ≥4 on the NRS over three different months at
outpatient visits during the calendar year 2008, which is consistent with the International
Association for the Study of Pain (25) and VA clinical policy (26). If patients reported their
first pain score of ≥4 in November or December 2008, the first two months of 2009 were
considered for inclusion. We gave each patient who met the aforementioned criteria an
index date on the day of the third recorded pain score ≥4 during 2008. We excluded patients
if they had a cancer diagnosis in the year prior to the index date, were currently enrolled in a
VA opioid substitution program or palliative care program, or had surgery within 6 months
of the index date.
Data Obtained
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We obtained demographic data including sex, age, race, marital status, VA facility, and VA
service-connected disability status for all subjects at the index date. Measures of general
health included body mass index (BMI), Charlson Comorbidity Score (27), average pain
score as measured on the NRS, pain diagnoses, and mental health diagnoses including
substance use disorder. We calculated BMI based on height and weight measurements at
outpatient visits available on each patient’s index date. We used past-year inpatient
hospitalization data, and outpatient diagnoses based on International Classification of
Diseases, Clinical Modification – 9th Revision (ICD-9-CM) to calculate Charlson
Comorbidity scores (27). Average pain scores were based on all NRS scores obtained over
12 months after each patient’s index date. We measured ICD-9-CM pain diagnoses over the
12 months before each patient’s index date and classified them in the following categories:
fibromyalgia, inflammatory bowel disease, low back pain, migraine headache, neck or joint
pain, neuropathy, and arthritis. ICD-9-CM mental health diagnoses included major
depressive disorder, dysthymic disorder, bipolar disorder, panic disorder, post-traumatic
stress disorder, other anxiety disorder, and schizophrenia and were included if noted within
the 12 months prior to the index date. Substance use disorders were defined as none, tobacco
abuse, cannabis abuse or dependence, alcohol abuse or dependence, opioid abuse or
dependence, or other drug abuse or dependence (cocaine, methamphetamine,
benzodiazepine, and polysubstance). All diagnostic data were based on clinician-rendered
clinical diagnoses made in the context of usual care.
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We obtained specific measures of medical care related to pain including primary care
utilization as defined by completed visits to a primary care provider (PCP) and documented
PCP telephone encounters (provider-patient completed calls), prescription of COT (defined
as prescription of ≥90 consecutive days of opioid therapy from the index date) (28), record
of an emergency department visit with any pain diagnosis (acute or chronic) as the primary
diagnosis, and receipt of physical therapy as measured by at least one completed physical
therapy appointment. We collected all measures of medical care for 12 months following
each patient’s index date.
To better understand sex differences among patients prescribed COT, we performed a
secondary analysis measuring the following in patients prescribed COT: average daily
opioid dose converted to morphine equivalents per day (MED) (29), type of opioid
prescribed (short acting opioid versus long acting opioid or both), co-prescription of a
benzodiazepine, receipt of urine drug testing, and accidental or intentional drug overdose
based on ICD-9-CM codes (977.9A-W, 950.5E, 855.9B). We collected all COT measures
over the one year after each patient’s index date.
Statistical Analysis
We analyzed demographic and clinical data using chi-square tests for categorical variables
and t-test for continuous variables using SPSS software (Version 19, IBM, Armonk, New
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York). We constructed logistic regression models using Stata (Version 10, Stata
Corporation, College Station, Texas) to investigate associations between medical care and
sex, both with and without controlling for demographic and clinical factors. These models
employed standard errors that had been corrected for clustering of individual VA sites
within the larger VISN-20. We adjusted for a number of covariates in a multi-step, nonautomated fashion in order to better understand the observed relationship between sex and
medical care differences. In the initial multivariate regression, demographic characteristics
(age, sex, marital status, race, and service connection) were inserted into the model. The
second multivariate regression model included demographic characteristics and pain
conditions (average pain score, fibromyalgia, neck pain, arthritis, low back pain,
inflammatory bowel disease, neuropathy, presence of multiple pain diagnoses). The third
multivariate regression model included demographic characteristics, pain conditions, and
mental health and substance use disorders (major depressive disorder, dysthymia, bipolar
disorder, panic disorder, post-traumatic stress disorder, other anxiety disorder, tobacco use,
alcohol abuse or dependence, cannabis abuse or dependence, opioid abuse or dependence,
and other drug use or dependence). The final multivariate regression model controlled for
demographic data, pain conditions, mental health and substance use disorders, and medical
comorbidity as measured by the Charlson Comorbidity Score. Primary outcome measures
were primary care utilization reported as visits to PCP and calls to the PCP, prescription of
COT, ≥1 emergency department visits for a pain diagnosis in one year, and participation in
physical therapy.

NIH-PA Author Manuscript

We also assessed the importance of effect modification using the significance of interaction
terms in the logistic regression models. Age and average pain score exhibited significant
interaction in the analysis when COT was the main outcome, thus further stratified analysis
was performed to assess sex differences in medical care based on age using unadjusted and
adjusted multivariate logistic regression, corrected for clustering.

Results
Demographic characteristics
We identified 17,583 veteran patients with moderate to severe CNCP occurring during
calendar year 2008 who met inclusion/exclusion criteria. Of these patients, 1,945 were
women (11%) and 15,638 (89%) were men. Demographic characteristics are reported in
Table 1. All baseline demographic characteristics were significantly different between
women and men. Women were younger, more likely to be white, and more likely to have a
VA service-connected disability.
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Pain and medical diagnoses characteristics
Table 1 also shows differences in pain and medical diagnostic data. Women had lower
Charlson Comorbidity Scores, indicating that they had a lower burden of medical illness.
Women and men’s average reported pain intensity did not significantly differ (5.65 versus
5.61, p = 0.371, respectively). The following pain-related diagnoses were more common in
women: fibromyalgia (15% versus 4%, p = <0.001), inflammatory bowel disease (3% versus
2%, p = <0.001), low back pain (53% versus 50%, p = 0.006), migraine headache (16%
versus 9%, p = <0.001), neck or joint pain (71% versus 57%, p = <0.001), and rheumatism/
arthritis (51% versus 43%, p = <0.001). Women were also more commonly diagnosed with
two or more concurrent pain-related conditions (67% versus 56%, p = <0.001). In this
cohort, women also had higher rates of mental health diagnoses and lower rates of substance
use disorders (Table 1).
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The results of logistic regression to examine associations between sex and medical care are
shown in Table 2. In the final model, the odds of a woman being prescribed COT were
lower compared to men (AOR 0.67, 95% CI 0.58–0.78). Analyses of patients prescribed
COT are shown in Table 3. Within this subgroup of patients, the average morphine
equivalents per day (MED) was not significantly different between women and men (44 mg
MED versus 46 mg MED, p = 0.340). The odds of women and men being prescribed high
dose opioids (≥120 MED), being prescribed short acting versus long acting opioids, or
having a drug overdose did not significantly differ. The odds that a woman prescribed COT
would receive a urine drug test were lower (AOR 0.52, 95% CI 0.40–0.66), and the odds
that a woman prescribed COT would also be prescribed a benzodiazepine were higher than
for a man prescribed COT (AOR 1.48, 95% CI 1.14–1.91).
In the stratified analysis assessing sex differences in receipt of COT by age (Table 4), the
differences between women and men were significant in all age groups, but became less
pronounced in older veterans. The odds that a young woman received COT were lower than
that of a young man (AOR 0.57, 95% CI 0.38–0.86). The odds that an older woman would
be prescribed COT remained lower than men (AOR 0.77, 95% CI 0.61–0.96), though less
so.
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The odds of a woman participating in physical therapy (AOR 1.19, 95% CI 1.05–1.33) and
visiting the emergency department at least once for a pain-related complaint (AOR 1.40,
95% CI 1.18–1.65) were higher than that for men. There were no statistically significant
differences in regard to number of primary care visits; however, the odds of a woman calling
her PCP > 10 times in one year was higher than for a man (AOR 1.20, 95% CI 1.01–1.44).

Discussion
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This study elucidates sex differences in CNCP care in a large cohort of veteran patients who
receive care from a VA Medical Center in the Pacific Northwest. Our results show that
among veterans with CNCP, women had a higher prevalence of several pain diagnoses and
were more likely to have two or more pain diagnoses. Compared to men, women with
CNCP had lower odds of being prescribed COT, but higher odds of having an emergency
department visit for a pain-related diagnosis, calling their PCP > 10 times, and receiving
physical therapy. Of patients prescribed COT, women had lower odds of urine drug testing
and higher odds of being prescribed concurrent benzodiazepines. In stratified analysis, sex
differences in prescriptions of COT for CNCP were more pronounced in younger veterans
than older veterans. All of the aforementioned differences persisted after adjustment for
demographic and diagnostic data. These data suggest that there are opportunities to improve
the pain care of female veterans in order to decrease ED visits for pain complaints, provide
effective analgesia, and monitor risks of COT.
Contrary to prior research, this study did not identify significant differences between
utilization of primary care visits for veteran women compared to men. Studies in the civilian
population have suggested that women are more likely to seek medical care for their pain
conditions (3, 4, 16) and receive COT (16, 17). Notable differences between those studies
and ours is that many of the patients in the civilian studies were older (>55 years of age),
privately insured, and identified via pain diagnosis rather than pain score (16, 17). Two
studies in the veteran population showed that women with chronic pain had high health care
utilization (7, 19). One of these studies surveyed a small cohort of veteran women in a
general medicine population and found that women with CNCP reported seeing their PCPs
≥12 times in a year (19). The other study compared health care utilization between male and
female veterans with chronic pain in a single VA Medical Center and reported that female
Pain Med. Author manuscript; available in PMC 2014 December 01.
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veterans had more primary care visits, physical therapy visits, and visits specifically to
address a pain complaint (7). Our results did not identify significant sex differences between
PCP visit utilization; though women were more likely to have more telephone contact,
which may obviate the need for in-person visits. The discrepancy observed between our
study and the two former studies may be attributed to differences in the samples studied—
the two other studies had smaller samples and used different criteria to define chronic pain.
Given the large and diverse settings of our study, the results may be more indicative of
differences in health care utilization between the sexes. The absence of a significant
difference in primary care utilization may be positive; however, the larger number of women
seeking care in the ED and over the phone may suggest that women are not finding adequate
pain treatment during their primary care visits as compared to men. Finally, the lack of
difference in utilization may be explained by a large number of women seeking medical care
outside of the VA system (20).
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There are limited published data examining sex differences in COT prescription. The
reasons for the differences in care identified in this study are not clear since women and men
have similar levels of reported pain intensity and see their primary care providers at similar
rates. This could suggest that women’s pain is sub-optimally treated. Conversely, it could be
indicative of women being offered other modalities of treatment prior to COT prescription
or of positive clinical care since pain diagnoses like fibromyalgia and migraine headache
may not be responsive to COT (30, 31). However, the odds of being prescribed COT
persisted after controlling for these diagnoses. Women had greater odds of participating in
physical therapy, which has been shown to be effective for treating disorders such as
fibromyalgia and headache (30, 31). Further research will be needed to understand the
observed differences in the types of treatment provided, though these data would suggest
that men are prescribed COT more liberally than women in the VA system.
The results of this study are consistent with prior research examining COT prescription
among women which showed that older women were more likely to be prescribed COT than
younger women (17), and demonstrating it for the first time among female veterans. The
reason for this difference is not clear, though possibilities might include that clinicians are
less likely to trust pain reports of younger female veterans or clinicians thinking that COT is
more risky in terms of abuse in younger women. Patient preference may have also played a
role. Further research would be needed to elucidate this.
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Among veterans who were prescribed COT, however, we found differences in their receipt
of urine drug testing and prescription of benzodiazepines. Of the women who are prescribed
COT, there is less monitoring of risk compared to men, despite the higher use of
benzodiazepines which are known to increase the risk of side effects when concurrently
prescribed with opioids. Higher rates of substance use disorders were observed in men, and
previous research has shown that providers are more likely to order urine drug testing in
patients with CNCP and a history of substance use disorder (32).
Limitations
There are several limitations that are important to consider when interpreting the results of
this study. This study is limited by the baseline differences between men and women.
Though we adjusted for a large number of potential confounders, it is possible that our
results were biased by unmeasured confounders. Secondly, aspects of our inclusion sample
may have resulted in a skewed sample. Participants were identified based on pain scores
identified in the medical record, which may be an underestimation of pain intensity (33).
This sample may also be overrepresented by high utilizers of care given our inclusion
criteria of requiring three or more pain scores in a given year; however, this is a population
with known high use of medical care. Additionally, the results were reliant on the accuracy
Pain Med. Author manuscript; available in PMC 2014 December 01.
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of diagnostic codes recorded in the medical record in usual care. These results were not
confirmed with laboratory data or via clinical examination. We did not have access to
information regarding patients’ use of non-prescribed over-the-counter analgesics or other
non-pharmacological modalities of pain treatment. This is a limitation since opioids may be
only one part of the multi-faceted treatment for CNCP. We also were not aware if patients
were receiving care outside of the VA system, this may have been a particular issue for
women who may receive more of their medical care outside of the VA. Finally, patients
included in the study were veterans receiving care in the Pacific Northwest and may not be
generalizable to non-veterans or patients receiving care in other VAs where women’s access
to medical care may be different.
Summary
This study describes sex differences in key medical care factors related to the treatment of
veterans with moderate to severe CNCP. The results demonstrate that female veteran
patients have lower odds than male veteran patients of being prescribed COT for CNCP and
higher odds of seeking pain treatment in the emergency department. Finally, the study shows
that the sex difference in COT prescription is most pronounced in younger female veterans.
These findings indicate that more research is needed to better understand if the observed
differences are a reflection of differences in access to services, patient preference, disparate
care, or sound clinical judgment.
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Table 1

Sex differences in the demographic and clinical characteristics of VA patients with chronic non-cancer pain.
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Women (N=1945)

Men (N=15,638)

p-value

48.7 (SD 13.3)

57.1 (SD 12.5)

<0.001

White

1185 (60.9%)

9306 (56.5%)

Black

169 (8.7%)

1023 (6.5%)

Other

61 (3.1%)

452 (2.9%)

Unknown/Declined to answer

530 (27.2%)

4857 (31.1%)

Age, Mean (SD)
Race

<0.001

Marital Status

<0.001

Married

629 (32.3%)

7867 (50.3%)

Never Married

344 (17.7%)

1470 (9.4%)

Widowed

123 (6.3%)

717 (4.6%)

Separated or Divorced

819 (42.1%)

5300 (33.9%)

Unknown

NIH-PA Author Manuscript

30 (1.5%)

283 (1.8%)

VA Service Connected

1458 (75%)

10604 (67.8%)

<0.001

BMI, Mean (SD)

31.60 (SD 7.4)

31.24 (SD 6.7)

0.036

Charlson Comorbidity Score, Mean (SD)

0.68 (SD 1.0)

1.24 (SD 1.6)

<0.001

Average Pain Score, Mean (SD)

5.65 (SD 2.06)

5.61 (SD 2.08)

0.371

Presence of >1 pain diagnoses

1303 (67%)

8678 (55.5%)

<0.001

Fibromyalgia

300 (15.4%)

572 (3.7%)

<0.001

Inflammatory bowel disease

62 (3.2%)

287 (1.8%)

<0.001

Chronic Low back pain

1039 (53.4%)

7835 (50.1%)

0.006

Migraine Headache

311 (16%)

1325 (8.5%)

<0.001

Chronic Neck or Joint Pain

1387 (71.3%)

8979 (57.4%)

<0.001

Neuropathy

85 (4.4%)

1214 (7.8%)

<0.001

Arthritis

982 (50.5%)

6791 (43.4%)

<0.001

Major Depressive Disorder

1045 (53.7%)

5722 (36.6%)

<0.001

Dysthymic disorder

183 (9.4%)

895 (5.7%)

<0.001

Bipolar disorder

207 (10.6%)

837 (5.4%)

<0.001

Panic disorder

99 (5.1%)

399 (2.6%)

<0.001

Posttraumatic stress disorder

664 (34.1%)

4107 (26.3%)

<0.001

Other anxiety disorder

368 (18.9%)

1771 (11.3%)

<0.001

Schizophrenia

61 (3.1%)

485 (3.1%)

0.933

None

1416 (72.8%)

9871 (63.1%)

<0.001

Tobacco Abuse

421 (21.6%)

4468 (28.6%)

<0.001

Cannabis Abuse or Dependence

41 (2.1%)

614 (3.9%)

<0.001

Alcohol Abuse or Dependence

144 (7.4%)

2313 (14.8%)

<0.001

Opioid Abuse or Dependence

34 (1.7%)

422 (2.7%)

0.01

Pain Diagnoses*

Mental Health Diagnoses

NIH-PA Author Manuscript

Substance Use Disorders
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NIH-PA Author Manuscript

Other Drug† Abuse or Dependence

Women (N=1945)

Men (N=15,638)

p-value

77 (4.0%)

1172 (7.5%)

<0.001

Note.
*

ICD-9-CM codes include fibromyalgia 729.1–729.19, Inflammatory bowel disease 558.9, Chronic low back pain 722–722.99; 724–724.99;
Migraine headache 784.0; 346.9; Chronic neck or joint pain without fibromyalgia 716–719.99; 723–723.99; 729–729.09; 729.2–729.99;
Neuropathy 337.0–337.19; 356–357.99; 377–377.99; Rheumatism or Arthritis 712–712.99; 714–716.99; 720–720.99; 729–729.99.
†

Includes abuse and dependence to cocaine, methamphetamine, benzodiazepine, or multiple substances.

NIH-PA Author Manuscript
NIH-PA Author Manuscript
Pain Med. Author manuscript; available in PMC 2014 December 01.

NIH-PA Author Manuscript

NIH-PA Author Manuscript
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206 (10.6)

421 (21.6)

386 (19.8)

522 (26.8)

616 (31.7)

233 (12.0)

533 (27.4)

532 (27.4)

1600 (10.2)

3949 (25.3)

4294 (27.5)

5167 (33.0)

2228 (14.2)

1311 (8.4)

3532 (22.6)

5125 (32.8)

Men (n=15,638) n
(%)

1.04 (0.89–1.21)

0.82 (0.48–1.40)

0.65 (0.40–1.08)

0.74 (0.52–1.06)

2.79 (0.90–8.62)

1.48 (1.35–1.63)

1.29 (1.14–1.46)

0.77 (0.67–0.90)

Unadjusted OR (95%
CI)

1.23 (1.05–1.43)

0.90 (0.54–1.50)

0.67 (0.40–1.12)

0.70 (0.49–1.02)

2.57 (0.83–7.98)

1.50 (1.28–1.74)

1.26 (1.12–1.42)

0.73 (0.62–0.85)

Model 1: Adjusted OR
(AOR) (95% CI)†

Variables in Model 1, Demographics characteristics: age, sex, revised marital status, race, and service connection.

1.20 (1.02–1.42)

0.87 (0.53–1.41)

0.66 (0.39–1.11)

0.72 (0.50–1.03)

2.69 (0.89–8.18)

1.48 (1.25–1.76)

1.21 (1.08–1.35)

0.70 (0.60–0.82)

Model 2: AOR (95%
CI)‡

1.13 (0.96–1.35)

0.85 (0.50–1.42)

0.66 (0.39–1.12)

0.72 (0.51–1.02)

2.76 (0.90–8.53)

1.39 (1.17–1.66)

1.18 (1.05–1.32)

0.66 (0.57–0.77)

Model 3: AOR (95%
CI)§

1.20 (1.01–1.44)

0.87 (0.52–1.45)

0.66 (0.39–1.13)

0.71 (0.50–1.00)

2.78 (0.90–8.56)

1.40 (1.18–1.65)

1.19 (1.05–1.33)

0.67 (0.58–0.78)

Model 4: AOR (95%
CI)||

Variables in Model 4, Demographics characteristics + pain conditions + mental health and substance use disorders + Charlson Comorbidity Index.

||

Variables in Model 3, Demographics characteristics + pain conditions + mental health and substance use disorders: major depressive disorder, dysthymia, bipolar disorder, panic disorder, post-traumatic
stress disorder, other anxiety disorder, tobacco use, alcohol abuse or dependence, cannabis abuse or dependence, opioid abuse or dependence, other drug use or dependence.

§

Variables in Model 2, Demographics characteristics + pain conditions: average pain score, fibromyalgia, neck pain, arthritis, low back pain, inflammatory bowel disease, neuropathy, multiple pain
diagnoses

‡

†

Note. All analyses clustered by VA VISN-20 Site. In all analyses, male is the reference category.

Women

>10 times/year

PCP Call

Women

≥9 visits/year

Women

5–8 visits/year

Women

2–4 visits/year

Women

≤ 1 visits/year

PCP Utilization

Women

ED Visit for pain

Women

Physical therapy

Women

Prescription

Chronic Opioid

Women
(n=1945) n (%)

Unadjusted and Adjusted Analysis of Sex Differences in the Medical Care of VA patients with chronic non-cancer pain.
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NIH-PA Author Manuscript
7 (1.3)

103 (19.4)

204 (38.3)

174 (32.7)

63 (11.8)

295 (55.5)

29 (0.6)

1234 (24.1)

1302 (25.4)

1734 (33.8)

557 (10.9)

2834 (55.3)

268 (5.3)

28 (5.3)

2.34 (0.88–6.25)

0.76 (0.63–0.90)

1.83 (1.53–2.17)

0.95 (0.75–1.20)

1.10 (0.82–1.48)

1.00 (0.76–1.33)

1.01 (0.73–1.38)

Unadjusted OR (95% CI)*

2.19 (0.73–6.58)

0.52 (0.40–0.66)

1.48 (1.14–1.91)

0.85 (0.68–1.07)

0.99 (0.72–1.36)

1.17 (0.91–1.51)

0.95 (0.74–1.21)

Adjusted OR (95% CI)†
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Benzodiazepines include alprazolam, clonazepam, clordiazepoxide, diazepam, lorazepam, oxazepam, temazepam, and triazolam.

||

Long-acting opioids include methadone, morphine sustained-release, oxycodone controlled-release, and transdermal fentanyl.

Short-acting opioids include codeine sulfate, hydrocodone, hydromorphone immediate-release (IR), morphine IR, oxycodone IR, and propoxyphene

§

‡

Variables in Model: age, average pain score, sex, major depressive disorder, Tobacco use, fibromyalgia, neck pain, arthritis, low back pain, inflammatory bowel disease, neuropathy, marital status, race,
service Connection, Charlson Comorbidity Index, multiple pain diagnoses, dysthymia, bipolar disorder, panic disorder, post-traumatic stress disorder, other anxiety disorder, alcohol abuse or dependence,
cannabis abuse or dependence, opioid abuse or dependence, other drug use or dependence.

†

Note. All analyses clustered by VA VISN-20 Site. In all analyses, the predictor is sex and male is the reference category.

Women

Sustained a Drug Overdose

Women

Urine Drug Test Obtained

Women

Prescribed a Benzodiazepine||

Women

Prescribed a Short and Long Acting Opioid

Women

Prescribed a Long Acting Opioid Only§

Women

Prescribed a Short Acting Opioid Only‡

Women

Prescribed High Dose Opioids (≥120mg Morphine Equivalents per Day)

Men (n = 5,125) n (%)

Women (n=532) n (%)

Unadjusted and Adjusted Analysis of Sex Differences in Chronic Opioid Therapy descriptors in VA patients with Chronic Non-Cancer Pain receiving
Chronic Opioid Therapy

NIH-PA Author Manuscript

Table 3
Weimer et al.
Page 13

NIH-PA Author Manuscript

NIH-PA Author Manuscript
327 (16.8)

6542 (41.8)

7725 (49.4)

1371 (8.8)

Men (n=15,638) n (%)

0.83 (0.66–1.05)

0.78 (0.66–0.93)

0.57 (0.41–0.78)

Unadjusted OR (95%CI)

0.77 (0.61–0.96)

0.75 (0.66–0.86)

0.57 (0.38–0.86)

Adjusted OR (95% CI)*

Variables in Model: age, average pain score, sex, major depressive disorder, Tobacco use, fibromyalgia, neck pain, arthritis, low back pain, inflammatory bowel disease, neuropathy, marital status, race,
service Connection, Charlson Comorbidity Index, multiple pain diagnoses, dysthymia, bipolar disorder, panic disorder, post-traumatic stress disorder, other anxiety disorder, alcohol abuse or dependence,
cannabis abuse or dependence, opioid abuse or dependence, other drug use or dependence.

*

Note. All analyses clustered by VA VISN-20 Site. In all analyses, male is the reference category.

Women

≥60 (N = 6869)

Women

40–59 (N = 8868)

1143 (58.8)

475 (24.4)

18–39 (N = 1846)

Women

Women n=1945) n (%)

Age group in years

Sex Differences in the receipt of Chronic Opioid Therapy in VA patients with chronic non-cancer pain, stratified by age.
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